Cargando…
Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations
Interindividual variability in anatomical and physiological properties results in significant differences in drug pharmacokinetics. The consideration of such pharmacokinetic variability supports optimal drug efficacy and safety for each single individual, e.g. by identification of individual-specifi...
Autores principales: | Krauss, Markus, Tappe, Kai, Schuppert, Andreas, Kuepfer, Lars, Goerlitz, Linus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592188/ https://www.ncbi.nlm.nih.gov/pubmed/26431198 http://dx.doi.org/10.1371/journal.pone.0139423 |
Ejemplares similares
-
Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification
por: Krauss, Markus, et al.
Publicado: (2013) -
Physiologically Based Pharmacokinetic (PBPK) Modeling of Interstrain Variability in Trichloroethylene Metabolism in the Mouse
por: Chiu, Weihsueh A., et al.
Publicado: (2014) -
Development of a physiologically based pharmacokinetic (PBPK) population model for Chinese elderly subjects
por: Cui, Cheng, et al.
Publicado: (2021) -
Modeling Interindividual Variability in Physiologically Based Pharmacokinetics and Its Link to Mechanistic Covariate Modeling
por: Huisinga, W, et al.
Publicado: (2012) -
Translational learning from clinical studies predicts drug pharmacokinetics across patient populations
por: Krauss, Markus, et al.
Publicado: (2017)